Combination of cryosurgery and topical imiquimod: Does timing matter for successful immunocryosurgery?

Cryobiology

Volumn 59, Issue 1, 2009, Pages 116-117

  Bassukas, Ioannis D ^a   Gaitanis, Georgios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CLINICAL EFFECTIVENESS; CRYOSURGERY; DENDRITIC CELL; ELECTROSURGERY; GROWTH INHIBITION; IMMUNE RESPONSE; IMMUNOCRYOSURGERY; LETTER; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; TIME; VASCULAR TUMOR;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; APOPTOSIS; COMBINED MODALITY THERAPY; CRYOSURGERY; DENDRITIC CELLS; HUMANS; IMMUNOSUPPRESSION; IMMUNOTHERAPY; LENTIGO; SKIN NEOPLASMS; TIME FACTORS; TOLL-LIKE RECEPTORS;

EID: 67649395508     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2009.04.011     Document Type: Letter

References (17)

1. Bassukas I.D., Gamvroulia C., Zioga A., et al. Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna. International Journal of Dermatology 47 (2008) 519-521
2. Crittenden M.R., Thanarajasingam U., Vile R.G., and Gough M.J. Intratumoral immunotherapy: using the tumour against itself. Immunology 115 (2005) 11-22
3. den Brok M.H., Sutmuller R.P., Nierkens S., et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumor immunity. British Journal of Cancer 95 (2006) 896-905
4. den Brok M.H., Sutmuller R.P., Nierkens S., et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. Cancer Research 66 (2006) 7285-7292
5. G. Gaitanis, K. Nomikos, E. Vava, et al., Immunocryosurgery for basal cell carcinomas: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application, Journal of the European Academy of Dermatology and Venereology (2009), in press.
6. Kaporis H.G., Guttman-Yassky E., Lowes M.A., et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. Journal of Investigative Dermatology 127 (2007) 2391-2398
7. Lee J.R., Shin J.H., Park J.H., et al. Combined treatment with intratumoral injection of dendritic cells and topical application of imiquimod for murine melanoma. Clinical Experimental Dermatology 32 (2007) 541-549
8. Machlenkin A., Goldberger O., Tirosh B., et al. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clinical Cancer Research 11 (2005) 4955-4961
9. Redondo P., Del Olmo J., Lopez-Diaz de Cerio A., et al. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. Journal of Investigative Dermatology 127 (2007) 1673-1680
10. Sabel M.S. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 58 (2009) 1-11
11. Schön M.P., and Schön M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 27 (2008) 190-199
12. Sidbury R., Neuschler N., Neuschler E., et al. Topically applied imiquimod inhibits vascular tumor growth in vivo. Journal of Investigative Dermatology 121 (2003) 1205-1209
13. Tan J.K., Thomas D.R., Poulin Y., et al. Efficacy of imiquimod as an adjuvant to cryotherapy for actinic keratoses. Journal of Cutaneous Medicine and Surgery 11 (2007) 195-201
14. Udagawa M., Kudo-Saito C., Hasegawa G., et al. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and bacillus x cell wall skeleton stimulation. Clinical Cancer Research 12 (2006) 7465-7475
15. Urosevic M., Dummer R., Conrad C., et al. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. Journal of the National Cancer Institute 97 (2005) 1143-1153
16. Urosevic M., Maier T., Benninghoff B., et al. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Archives of Dermatology 139 (2008) 1325-1332
17. Wolf I., Kodama K., Cerroni L., and Kerl H. Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment. American Journal of Dermatopathology 29 (2007) 237-241